Form 4: Organon & Co. Executive Susanne Fiedler Reports Stock Transactions
SEC Form 4 Filing
Chief Commercial Officer Susanne Fiedler reports the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations.
Summary
- On May 4, 2024, Susanne Fiedler, Chief Commercial Officer of Organon & Co., reported transactions involving Organon common stock.
- Fiedler had 4,989 restricted stock units (RSUs) vest, each representing a contingent right to receive one share of Organon common stock.
- Also on May 4, 2024, Fiedler disposed of 1,589 shares of common stock at a price of $19.61 per share to satisfy tax obligations related to the vesting of the RSUs.
- Following these transactions, Fiedler directly owns 50,664 shares of Organon common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice and required by the SEC to ensure transparency and prevent insider trading.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine executive stock transaction.
Key Dates
| Date | Description |
|---|---|
| 05/04/2022 | One-third of the RSUs vested. |
| 05/04/2023 | One-third of the RSUs vested. |
| 05/04/2024 | RSUs vested; shares disposed of for tax obligations. |
| 05/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.